CGM Hypoglycemia: How to Handle Low Glucose Alerts

A low glucose alert on a continuous glucose monitor is a prompt to act, but not necessarily to panic. Most CGM low alerts fire when your sensor glucose drops to or below 70 mg/dL, or when the device predicts you’ll reach that level within the next 20 to 30 minutes. The right response depends on context: whether you feel symptoms, whether the reading could be a false alarm, and whether an automated insulin system is already adjusting your dose. Understanding the signal and what sits behind it lets you treat real lows quickly while avoiding the common trap of overtreating and spiking high afterward.

Why Your CGM Reading Is Not Exactly Your Blood Sugar

A CGM sensor sits in the interstitial fluid just beneath your skin, not directly in your bloodstream. Glucose moves from blood vessels into that fluid with a short delay. In controlled studies on healthy adults, the physiological lag between blood glucose and interstitial glucose is roughly five to six minutes under stable conditions.

¹ That sounds minor, but when glucose is falling fast, even a few minutes of lag means your actual blood sugar may already be lower than the number on your screen. Blood and interstitial glucose are linked by a dynamic equilibrium that creates both a time gap and a magnitude gap between the two readings, and the gap widens when glucose is changing rapidly.²

During exercise, the practical lag can stretch well beyond six minutes. One study of adults with type 1 diabetes found that the CGM reading lagged behind capillary blood glucose by an average of about 12 minutes during prolonged aerobic activity, and the sensor’s error rate also climbed.³ The takeaway is practical: if you feel low during a workout but your CGM still shows a safe number, trust your body. A fingerstick can confirm what the sensor hasn’t caught up to yet.

Is the Alert Real? Sorting True Lows From False Alarms

Not every low alert means your blood sugar is actually low. One of the most common false alarms happens at night when you roll onto the arm or abdomen where the sensor sits. The pressure on surrounding tissue reduces local blood flow, and the sensor reads a sudden glucose drop that doesn’t reflect your actual level. Research has shown these so-called compression lows produce readings more than 25 mg/dL away from the true value, and they’re strongly correlated with sleeping on the sensor.⁴ If you get a low alert at 3 a.m. and your trend arrow shoots down suddenly from a flat line, the first move is to shift your position and wait a couple of minutes for the reading to recover. If it does, you likely had a compression artifact rather than a genuine low.

Certain medications and substances can also throw off CGM accuracy. A pilot study found that acetaminophen, lisinopril, albuterol, and even wine appeared to interfere with commonly used CGM devices, producing readings that diverged from actual plasma glucose.⁵ The extent of interference depends on which sensor you use. Testing of a fluorescence-based implantable CGM found that acetaminophen and vitamin C did not produce meaningful interference at normal doses, though tetracycline and mannitol did.⁶ If you take any medication regularly and notice CGM readings that don’t match how you feel, it’s worth checking with a fingerstick.

Accuracy also tends to be worse exactly when you need it most: in the low range. A systematic review of CGM performance during hypoglycemia in hospitalized patients found that mean absolute relative difference ranged from about 8% to over 50%, with most studies reporting error rates above 15% when glucose was genuinely low.⁷ A study in hospitalized children confirmed the pattern, with the sensor’s average error at about 20% in the hypoglycemic range compared to roughly 14% in the hyperglycemic range.⁸ These are hospital settings, where patients may be sicker and conditions less stable, so the error margins at home are likely smaller. Still, the broader point holds: when your CGM says you’re low, it might be off by more than you’d expect, in either direction.

How to Treat a Confirmed Low

If symptoms or a fingerstick confirm the low, fast-acting carbohydrates are the standard treatment. The traditional recommendation is about 15 grams of glucose, then wait 15 minutes and recheck. Glucose tablets, juice, or regular soda all work. The reason for using fast-acting sugar rather than a candy bar or meal is speed: fat and protein slow digestion, and when glucose is falling you want the fastest possible absorption.

However, if you use an insulin pump with a predictive low-glucose suspend feature, new evidence suggests you may need less than 15 grams. One study found that when the pump had already suspended insulin delivery in response to a predicted low, the median carbohydrate needed to resolve hypoglycemia was only about 9 grams, with none of the events requiring a repeat dose.⁹ The pump’s insulin suspension does some of the work for you, so piling on the same 15 grams you would take without a pump tends to cause a rebound spike.

The Rebound Spike Problem

Overtreating lows is one of the most common frustrations for people using CGMs. You see a scary low number, you eat fast carbs, and then your glucose shoots well above range within the next hour or two. Real-world data show that rebound hyperglycemia after treated lows is frequent among people using insulin, and it happens more often during the day, which points to carbohydrate overcorrection as a major driver.¹⁰

CGM-based algorithms have been designed to address this. One approach uses the rate of glucose change and the trend direction to trigger smaller, earlier treatments rather than waiting for a confirmed low and then treating aggressively. In simulation testing, this kind of algorithm reduced the post-treatment glucose peak from a median of about 174 mg/dL down to around 137 mg/dL when sensor noise was factored in.¹¹ Real-time CGM with predictive alerts can help you quantify and reduce rebound spikes by making the amount and timing of your treatment more precise.¹² The practical lesson: treat with the minimum effective carbohydrate dose, wait, and watch the trend arrow before eating more.

Predictive Alerts and Threshold Settings

Most modern CGMs offer two types of low alerts. A threshold alert fires when glucose actually hits a set value, usually 70 or 55 mg/dL. A predictive alert fires when the sensor’s algorithm projects you’ll cross that line in the near future, typically within 20 minutes. The predictive alert gives you a head start to treat before the low actually arrives.

Real-world data from users of the Dexcom G6 showed that the transition from an older system to one with predictive low-glucose alerts was associated with a roughly 40% reduction in clinically significant hypoglycemia (glucose below 54 mg/dL) for users who set their low threshold at 70 mg/dL.¹³ In a hospital setting, turning on threshold alerts improved time in range by about 4 percentage points compared to having no alerts at all, though adding predictive alerts on top of threshold alerts didn’t produce a statistically clear additional benefit in that particular study.¹⁴

Where you set your low threshold matters. A threshold of 70 mg/dL catches more events but generates more alerts, some of which may not progress to symptomatic lows. A threshold of 55 mg/dL is quieter but gives you less lead time on genuinely dangerous drops. Many diabetes teams recommend keeping the urgent low alert at 55 mg/dL (since that level always warrants immediate action) and using the predictive alert or a custom alert at 70-80 mg/dL as your early warning system.

When Alarms Stop Working: Alert Fatigue

Getting too many alerts can backfire. If your phone or pump buzzes constantly with warnings you’ve learned to ignore, you’re experiencing alarm fatigue, and it’s a well-documented problem. A narrative review of CGM use in children and adolescents with type 1 diabetes found that alarm fatigue negatively affected daily life for patients and caregivers, and in some cases drove people to abandon CGM or pump therapy altogether.¹⁵ The concern isn’t just annoyance. When someone becomes desensitized, they’re less likely to respond appropriately to a real emergency alert.¹⁶

The fix is customization, not resignation. Most CGMs let you adjust which alerts are active, set different thresholds for day and night, and choose between vibration and sound. If you find yourself dismissing alerts reflexively, work with your care team to tighten which ones are truly needed and silence the rest. A smaller number of meaningful alerts you actually respond to is better than a constant stream you tune out.

Nocturnal Lows and Why You Might Sleep Through Them

Nighttime hypoglycemia is particularly dangerous because the usual defense mechanisms are blunted by sleep. Counter-regulatory hormone responses are weaker at night, and you’re not conscious to notice symptoms. CGM alarms are supposed to wake you, but evidence suggests the alarm’s effectiveness depends on how deep the low goes. Research using wearable sleep assessment found that severe nocturnal hypoglycemia episodes (level 2, below 54 mg/dL) are associated with deeper sleep and reduced behavioral arousal, meaning the alarm may be less effective at waking you during the lows that matter most.¹⁷

Automated insulin delivery systems offer a meaningful safety net here. Predictive low-glucose suspend technology can pause insulin delivery when the algorithm predicts a low is coming, often preventing it entirely. A systematic review and meta-analysis in children with type 1 diabetes found high-quality evidence that predictive low-glucose suspend reduced nocturnal time below 70 mg/dL by an average of about 26 minutes per night compared to standard pump therapy, without increasing hyperglycemia or diabetic ketoacidosis.¹⁸ Real-world data from another pump system confirmed that overnight time below 70 mg/dL dropped significantly once the predictive suspend algorithm was activated.¹⁹

For caregivers of young children with type 1 diabetes, remote monitoring can help fill the gap. A randomized crossover trial found that parents of children using CGM with remote monitoring reported significantly lower hypoglycemia fear scores, along with improvements in anxiety, sleep quality, and family stress compared to periods without remote monitoring.²⁰ Being able to see your child’s glucose on your own phone at 2 a.m. doesn’t just provide data; it reduces the grinding fear that keeps many parents from sleeping soundly.

When It’s Severe: Glucagon and When You Can’t Treat Yourself

If glucose drops low enough that someone becomes confused, loses consciousness, or has a seizure, oral carbohydrates are no longer safe because of the choking risk. This is where glucagon comes in. Glucagon is a hormone that triggers the liver to release stored glucose, and it’s available as an emergency rescue treatment.

Traditional injectable glucagon kits require mixing a powder with a liquid, drawing it into a syringe, and injecting. Under the stress of an emergency, handling errors are common.²¹ Nasal glucagon, which is delivered as a dry powder puff into one nostril, eliminates most of those steps. In simulation studies, about 87% of trained users found nasal glucagon easy to use, compared to roughly 55% for injectable glucagon, and over 90% of people with diabetes considered the nasal device safer during a severe event.²² A meta-analysis comparing the two routes found similar effectiveness, with no significant difference in the odds of resolving hypoglycemia between intranasal and injected glucagon.²³

If you or someone you live with uses insulin, keeping a glucagon kit accessible and making sure household members know how to use it is as important as any CGM setting. The best alert system in the world is only useful if the people around you can respond when the alert wakes them instead of you.

Exercise, Heat, and Other Situational Triggers

Exercise is one of the trickiest contexts for CGM-based hypoglycemia management. As noted earlier, the sensor lag increases during activity. But the accuracy picture during exercise is actually somewhat reassuring: one study comparing CGM performance during intermittent high-intensity and continuous moderate-intensity exercise found that overall accuracy was comparable between the two, with all CGM values falling in clinically acceptable zones.²⁴ The sensor tends to overestimate glucose more during sustained continuous exercise than during interval work.²⁵ That overestimation is the dangerous direction during a workout: the sensor says you’re fine while your blood sugar is actually dropping faster than the display suggests.

Environmental temperature adds another layer. A study of people with type 1 diabetes using real-time CGM found that higher ambient temperatures were associated with a nonlinear increase in hypoglycemia risk. At 25°C (about 77°F), the odds of a hypoglycemic event were roughly 26% higher than at more moderate temperatures, with the strongest effect on the same day as the exposure.²⁶ The mechanism likely involves increased insulin absorption from dilated blood vessels in warm weather, combined with greater glucose uptake by muscles. On hot days, especially if you’re also exercising, a more conservative approach to insulin dosing and more frequent CGM checks makes sense.

Hypoglycemia Unawareness and How CGM Helps

Some people with long-standing diabetes lose the ability to feel low blood sugar. They don’t get the shaking, sweating, or heart-pounding that normally serve as built-in alarms. This condition, called hypoglycemia unawareness, makes CGM alerts not just helpful but essential, since the device effectively replaces the body’s missing warning system.

Beyond simply catching lows in real time, CGM use may actually help restore some awareness over time. A post hoc analysis of older adults with type 1 diabetes found that after a year of CGM use, certain measures of impaired hypoglycemia awareness improved significantly.²⁷ The thinking is that by avoiding repeated lows, you allow the brain’s glucose-sensing mechanisms to recalibrate. Repeated hypoglycemia dulls the counter-regulatory response; avoiding it can partially restore it. For anyone who has been told they have hypoglycemia unawareness, wearing a CGM consistently and responding to alerts before glucose drops to dangerous levels may yield benefits beyond simply catching each individual low.

Automated Systems That Act Before You Do

The most advanced step beyond alerts is an automated system that doesn’t just warn you but does something about the problem. Predictive low-glucose suspend systems monitor the CGM reading and pause basal insulin delivery when the algorithm forecasts a low within the next 30 minutes or so. Hybrid closed-loop systems go further by also increasing insulin when glucose is running high. Both reduce the burden of responding to every alert manually.

The real-world data on predictive suspend technology is strong. In children, the meta-analysis cited earlier found it cut daily time below 70 mg/dL by about 17 minutes per day without causing more highs.¹⁸ This doesn’t eliminate lows entirely, but it meaningfully reduces both their frequency and severity, particularly at night.

Still, automated systems have limits. They can only suspend or reduce basal insulin; they can’t prevent a low caused by a bolus you gave 30 minutes ago for a meal that didn’t absorb as expected, or by a sudden burst of exercise. The alerts still matter even with automation, because there are situations where carbohydrate intake is the only fix fast enough.

Cost as a Barrier to Continuous Protection

For all the technology available, access remains uneven. In a 2017 survey of over 500 adults and more than 100 parents of children with type 1 diabetes, about 40% of those who had never tried CGM cited lack of insurance coverage as the main reason. Even among those with some coverage, the out-of-pocket cost of supplies was the top reason people stopped using their CGM.²⁸ A device that can prevent severe hypoglycemia is only useful if people can afford to keep wearing it. Insurance formularies, prior authorization requirements, and the ongoing cost of sensors and transmitters all create gaps in the safety net that the technology is designed to provide.

If cost is a concern, it’s worth checking manufacturer patient assistance programs, state Medicaid policies (which have been expanding CGM coverage in recent years), and whether your provider can document medical necessity in a way that satisfies your insurer’s criteria. Some people stretch sensor wear beyond the labeled duration to reduce costs, though this comes with trade-offs in accuracy as sensor performance tends to degrade after its approved lifespan.